[{"data":1,"prerenderedAt":65},["ShallowReactive",2],{"q-nurse-108-1-basic-medicine-011":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":34,"lastmod":64},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"explanationDeep":23,"topics":24,"freq":27},"nurse-108-1-基礎醫學-011","nurse-108-1-basic-medicine-011",108,1,11,"卵巢排卵（ovulation）時，下列何者不會隨著卵母細胞（oocyte）一起排出？",{"A":15,"B":16,"C":17,"D":18},"透明層（zona pellucida）","第一個極體（first polar body）","放射冠細胞（corona rediata cell）","內鞘細胞（theca interna cell）","D",null,[],"本題考點是排卵時隨卵母細胞一起排出的構造。依生殖組織學,排卵時卵巢釋出的是次級卵母細胞,其外包覆透明帶(zona pellucida)與由顆粒細胞形成的放射冠(corona radiata),並帶有第一極體,故A、B、C皆會隨之排出。D內鞘細胞(theca interna cell)屬濾泡壁的一部分、留在卵巢內轉變為黃體,並不隨卵排出,故選D。此題關鍵在區辨「隨卵排出的卵丘複合體(透明帶、放射冠、極體)」與「留在卵巢構成黃體的濾泡壁細胞(內鞘、顆粒層)」。","成熟濾泡在LH波動下破裂排卵,排出的卵丘-卵母細胞複合體包含次級卵母細胞、透明帶、放射冠與停於第一次減數分裂完成後產生的第一極體;卵須待受精後才完成第二次減數分裂。留在卵巢的顆粒細胞與內鞘細胞在LH作用下黃體化,分泌黃體素與雌激素維持可能的懷孕。內鞘細胞在濾泡期即負責提供雄性素前驅物供顆粒細胞經芳香酶轉為雌激素(兩細胞兩性腺素學說),是內分泌考點的延伸。",[25,28,30,32],{"term":26,"count":27},"排卵",3,{"term":29,"count":11},"放射冠與透明帶",{"term":31,"count":11},"內鞘細胞與黃體",{"term":33,"count":11},"卵丘複合體",[35,39,44,49,54,59],{"webId":36,"stem":37,"number":38,"year":10,"session":11},"nurse-108-1-basic-medicine-012","有關食道之敘述何者正確？",12,{"webId":40,"stem":41,"number":42,"year":10,"session":43},"nurse-108-2-basic-medicine-028","腎小球濾液與血漿的組成，主要差異為下列何者？",28,2,{"webId":45,"stem":46,"number":47,"year":48,"session":11},"nurse-109-1-basic-medicine-042","若家族中有第二型糖尿病的病史，罹患糖尿病的機會也將比較高。第二型糖尿病的遺傳模式屬於：",42,109,{"webId":50,"stem":51,"number":52,"year":53,"session":11},"nurse-110-1-basic-medicine-080","下列何種藥物治療蟠尾絲蟲（Onchocerca volvulus）引起的河川盲（river blindness）為首選藥物，而且病人副作用最小？",80,110,{"webId":55,"stem":56,"number":57,"year":58,"session":43},"nurse-111-2-basic-medicine-044","補體活化啟動一系列的蛋白質水解產生次單位「a」、「b」與其他次單位，具備不同的生物活性。下列何者是補體 C3b 主要的功能？",44,111,{"webId":60,"stem":61,"number":62,"year":63,"session":11},"nurse-113-1-basic-medicine-038","治療糖尿病的用藥canagliflozin，其主要作用機制為何？",38,113,"2026-09-04",1788510708198]